Qiming U.S. Ventures Management as of March 31, 2024
Portfolio Holdings for Qiming U.S. Ventures Management
Qiming U.S. Ventures Management holds 6 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Korro Bio (KRRO) | 36.9 | $33M | 368k | 90.00 | |
| Jasper Therapeutics Com New (JSPR) | 30.4 | $27M | 929k | 29.36 | |
| Tourmaline Bio (TRML) | 18.9 | $17M | 742k | 22.90 | |
| Hillevax (HLVX) | 10.4 | $9.3M | 559k | 16.63 | |
| Ventyx Biosciences (VTYX) | 2.5 | $2.3M | 412k | 5.50 | |
| Kezar Life Sciences (KZR) | 0.8 | $747k | 829k | 0.90 |
